Cargando…

The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications

Second-generation antipsychotics (SGAs) are the mainstay of treatment for schizophrenia and other neuropsychiatric diseases but cause a high risk of disruption to lipid metabolism, which is an intractable therapeutic challenge worldwide. Although the exact mechanisms underlying this lipid disturbanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hui, Cao, Ting, Zhang, Bikui, Cai, Hualin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905135/ https://www.ncbi.nlm.nih.gov/pubmed/36762113 http://dx.doi.org/10.3389/fphar.2023.1097284

Ejemplares similares

Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
por: Zhu, Zhenyu, et al.
Publicado: (2022)

Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs
por: Li, Nana, et al.
Publicado: (2020)

A Potential Mechanism Underlying the Therapeutic Effects of Progesterone and Allopregnanolone on Ketamine-Induced Cognitive Deficits
por: Cao, Ting, et al.
Publicado: (2021)

Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders
por: Chen, Qian, et al.
Publicado: (2021)

Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort
por: Janzen, Donica, et al.
Publicado: (2022)

Gut microbiota: A new therapeutic target for diabetic cardiomyopathy
por: Yuan, Suxin, et al.
Publicado: (2022)

Ferulic Acid Ameliorates Atherosclerotic Injury by Modulating Gut Microbiota and Lipid Metabolism
por: Gu, Yuyan, et al.
Publicado: (2021)

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil
por: Fulone, Izabela, et al.
Publicado: (2021)

Crosstalk Between Polygonatum kingianum, the miRNA, and Gut Microbiota in the Regulation of Lipid Metabolism
por: Dong, Jincai, et al.
Publicado: (2021)

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
por: Fang, Xinyi, et al.
Publicado: (2022)

Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children
por: Bahr, S M, et al.
Publicado: (2015)

The Effects of Erchen Decoction on Gut Microbiota and Lipid Metabolism Disorders in Zucker Diabetic Fatty Rats
por: Zhao, Tian, et al.
Publicado: (2021)

Effect of Metformin on Antipsychotic-Induced Metabolic Dysfunction: The Potential Role of Gut-Brain Axis
por: Luo, Chao, et al.
Publicado: (2019)

Canagliflozin Prevents Lipid Accumulation, Mitochondrial Dysfunction, and Gut Microbiota Dysbiosis in Mice With Diabetic Cardiovascular Disease
por: Wang, Xueliang, et al.
Publicado: (2022)

The Effect of Simvastatin on Gut Microbiota and Lipid Metabolism in Hyperlipidemic Rats Induced by a High-Fat Diet
por: Zhang, Qing, et al.
Publicado: (2020)

Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome
por: Skonieczna-Żydecka, Karolina, et al.
Publicado: (2018)

Editorial: Antipsychotics of New Generation: Where Are We now?
por: Lipina, Tatiana V., et al.
Publicado: (2021)

Asparagus cochinchinensis alleviates disturbances of lipid metabolism and gut microbiota in high-fat diet-induced obesity mice
por: Luo, Shiyue, et al.
Publicado: (2022)

Mechanisms of Triptolide-Induced Hepatotoxicity and Protective Effect of Combined Use of Isoliquiritigenin: Possible Roles of Nrf2 and Hepatic Transporters
por: Hou, Zhenyan, et al.
Publicado: (2018)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Yang, Sa, et al.
Publicado: (2022)

Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study
por: Sadowski, Alexander, et al.
Publicado: (2013)

Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications
por: Zhuang, Tongxi, et al.
Publicado: (2021)

Low-Dose of Bergamot-Derived Polyphenolic Fraction (BPF) Did Not Improve Metabolic Parameters in Second Generation Antipsychotics-Treated Patients: Results from a 60-days Open-Label Study
por: Bruno, Antonio, et al.
Publicado: (2017)

The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders
por: Coccurello, Roberto, et al.
Publicado: (2022)

Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond
por: Waddington, John L., et al.
Publicado: (2020)

Porphyran From Porphyra haitanensis Alleviates Obesity by Reducing Lipid Accumulation and Modulating gut Microbiota Homeostasis
por: Wang, Xueliang, et al.
Publicado: (2022)

Inclisiran: a new generation of lipid-lowering siRNA therapeutic
por: Zhang, Yanzhen, et al.
Publicado: (2023)

NSAID–Gut Microbiota Interactions
por: Maseda, Damian, et al.
Publicado: (2020)

The interplay between herbal medicines and gut microbiota in metabolic diseases
por: Wang, Lijie, et al.
Publicado: (2023)

Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids
por: Li, Qinyu, et al.
Publicado: (2021)

Effects of Xylooligosaccharides on Lipid Metabolism, Inflammation, and Gut Microbiota in C57BL/6J Mice Fed a High-Fat Diet
por: Li, Fang, et al.
Publicado: (2021)

Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice
por: Cai, Ting-Ting, et al.
Publicado: (2020)

Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations
por: Eum, Seenae, et al.
Publicado: (2016)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Chocolate, gut microbiota, and human health
por: Hayek, Nabil
Publicado: (2013)

The Role of Gut Microbiota in Atherosclerosis and Hypertension
por: Ma, Junli, et al.
Publicado: (2018)

Codonopsis pilosula Polysaccharide Improved Spleen Deficiency in Mice by Modulating Gut Microbiota and Energy Related Metabolisms
por: Cao, Lingya, et al.
Publicado: (2022)

Study on the Antipyretic and Anti-inflammatory Mechanism of Shuanghuanglian Oral Liquid Based on Gut Microbiota-Host Metabolism
por: Gao, Yan, et al.
Publicado: (2022)

Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives
por: Jiao, Shimeng, et al.
Publicado: (2022)

The Role of Gut Microbiota—Gut—Brain Axis in Perioperative Neurocognitive Dysfunction
por: Lu, Jian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lh21ei26iu8lstigks9u7b0gc8